Karin Badel

2.1k citations

27 papers · 1.6k indexed · h-index 14

Impact in

Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
Virology top 5%
- HIV Research and Treatment

Papers in ⓘ

Hematology 22
- Hematopoietic Stem Cell Transplantation 17
- Multiple Myeloma Research and Treatments 12
- Acute Myeloid Leukemia Research 10
Virology 2

Co-authors: Gary Calandra (13 shared papers)Gary Calandra (14 shared papers)Gary Bridger (6 shared papers)John F. DiPersio (3 shared papers)Jane L. Liesveld (3 shared papers)Daniel J. Weisdorf (4 shared papers)Neal Flomenberg (4 shared papers)Steven M. Devine (2 shared papers)
Journals: Blood (10 papers)Biology of Blood and Marrow Transplantation (7 papers)Bone Marrow Transplantation (3 papers)Clinical Pharmacology & Therapeutics (2 papers)Clinical Infectious Diseases (1 paper)
Partner nations: United States Canada Germany

In The Last Decade

Karin Badel

27 papers receiving 1.6k citations

Peers

Countries citing papers authored by Karin Badel

Since Specialization

Citations

This map shows the geographic impact of Karin Badel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Badel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Badel more than expected).

Fields of papers citing papers by Karin Badel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Badel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Badel. The network helps show where Karin Badel may publish in the future.

Co-authors

The 25 scholars most cited alongside Karin Badel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karin Badel Line = papers co-authored together Karin Badel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma Journal of Clinical Oncology ·Steven M. Devine, Neal Flomenberg, David H. Vesole, Jane L. Liesveld, Daniel J. Weisdorf, Karin Badel, Gary Calandra, John F. DiPersio	2004	327
2	Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection JAIDS Journal of Acquired Immune Deficiency Syndromes ·Craig W. Hendrix, Ann C. Collier, Michael M. Lederman, Dominique Schols, Richard B. Pollard, Stephen Brown, J. Brooks Jackson, Robert W. Coombs, Marshall J. Glesby, Charles Flexner, Gary Bridger, Karin Badel, R. T. MacFarland, Geoffrey Henson, Gary Calandra	2004	284
3	AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data Bone Marrow Transplantation ·Gary Calandra, John M. McCarty, Joseph P. McGuirk, Guido Tricot, Sue-Anne Crocker, Karin Badel, Birgith Engelst Grove, A Dye, Gary Bridger	2007	221
4	Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte–colony‐stimulating factor by single‐dose administration of AMD3100, a CXCR4 antagonist Transfusion ·W. Conrad Liles, Elin Rodger, Hal E. Broxmeyer, Christine Dehner, Karin Badel, Gary Calandra, Jeff Christensen, Brent L. Wood, Thomas H. Price, David C. Dale	2005	177
5	A Phase II Study of Plerixafor (AMD3100) plus G-CSF for Autologous Hematopoietic Progenitor Cell Mobilization in Patients with Hodgkin Lymphoma Biology of Blood and Marrow Transplantation ·Amanda F. Cashen, Sandra Lopez, Feng Gao, Gary Calandra, Ron MacFarland, Karin Badel, John F. DiPersio	2008	107
6	Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization Bone Marrow Transplantation ·Michael J. Dugan, Richard T. Maziarz, Jack W. Singer, Auayporn Nademanee, Jane L. Liesveld, Karin Badel, C. Dehner, Colleen Gibney, Gary Bridger, Gary Calandra	2009	103
7	Treatment with Plerixafor in non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF: Implications for the Heavily Pretreated Patient Biology of Blood and Marrow Transplantation ·Patrick J. Stiff, Ivana N. Micallef, Philip L. McCarthy, Margarida Magalhaes‐Silverman, Daniel J. Weisdorf, Mary Territo, Karin Badel, Gary Calandra	2009	86
8	A pharmacokinetic-pharmacodynamic model for the mobilization of CD34 hematopoietic progenitor cells by AMD3100 Clinical Pharmacology & Therapeutics ·Nathan A. Lack, B. Green, David C. Dale, Gary Calandra, H. Lee, R. T. MacFarland, Karin Badel, W. Conrad Liles, Gary Bridger	2005	61
9	Proof of Activity with AMD11070, an Orally Bioavailable Inhibitor of CXCR4‐Tropic HIV Type 1 Clinical Infectious Diseases ·Graeme Moyle, Edwin DeJesus, Marta Boffito, Rebecca S.Y. Wong, Colleen Gibney, Karin Badel, Ron MacFarland, Gary Calandra, Gary Bridger, Stephen Becker, (unknown)	2009	60
10	Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients Bone Marrow Transplantation ·Stefan Früehauf, Gerhard Ehninger, Kai Hübel, Julian Topaly, Hartmut Goldschmidt, Anthony D. Ho, Simone Müller, M Moos, Karin Badel, Gary Calandra	2009	50
11	Improved Mobilization of Peripheral Blood CD34 ⁺ Cells and Dendritic Cells by AMD3100 plus Granulocyte–Colony-Stimulating Factor in Non-Hodgkin's Lymphoma Patients Stem Cells and Development ·Yair Gazitt, César O. Freytes, Cagla Akay, Karin Badel, Gary Calandra	2007	43
12	Plerixafor (Mozobil®) Alone to Mobilize Hematopoietic Stem Cells from Multiple Myeloma Patients for Autologous Transplantation Biology of Blood and Marrow Transplantation ·Neal Flomenberg, Raymond L. Comenzo, Karin Badel, Gary Calandra	2010	23
13	A Pharmacokinetic Study of Plerixafor in Subjects with Varying Degrees of Renal Impairment Biology of Blood and Marrow Transplantation ·R. T. MacFarland, Marjie Hard, Robert J. Scarborough, Karin Badel, Gary Calandra	2009	18
14	A Pilot Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients with Advanced Hematological Malignancies. Blood ·Steven M. Devine, Jesper Bonde, David A. Hess, Terri M. Edwards, Daniel C. Link, Diane S. Sempek, Gary Calandra, Karin Badel, Jan A. Nolta, John F. DiPersio	2004	14
15	Treatment with AMD3100 in Multiple Myeloma or Non-Hodgkin’s Lymphoma Patients to Increase the Number of Peripheral Blood Stem Cells When Given with a Mobilizing Regimen of Chemotherapy and G-CSF. Blood ·Michael J. Dugan, Luke P. Akard, James Thompson, Auayporn Nademanee, Richard T. Maziarz, William Bensinger, Jane L. Liesveld, Karin Badel, Christine Dehner, Colleen Gibney, Gary Calandra, Jan Jansen	2004	8
16	AMD3100 with G-CSF for Autologous Peripheral Blood Progenitor Cell (PBPC) Mobilization in Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma (MM): Mobilization, Engraftment, and Pharmacokinetics (PK). Blood ·Stewart Douglas, Clayton A. Smith, R.T. McFarland, Karin Badel, Gary Calandra	2006	5
17	Pharmacokinetics of Plerixafor (AMD3100) in Volunteers with Renal Impairment. Blood ·R. T. MacFarland, Reginal B. Ewesuedo, Karin Badel, Gary Calandra	2007	5
18	AMD3100 Combined with Standard Doses of G-Csf Leads to Rapid, Consistent Mobilization of Hematopoietic Progenitor Cells in Patients with Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma. Blood ·Patrick J. Stiff, Ivana N. Micallef, Philip L. McCarthy, Margarida Magalhaes‐Silverman, Neal Flomenberg, Daniel J. Weisdorf, Guido Tricot, Mary Territo, Rafat Abonour, Karin Badel, Gary Calandra	2004	5
19	15: AMD3100 plus G-CSF mobilizes the majority of non-Hodgkin’s lymphoma (NHL), multiple myeloma (MM), and Hodgkin’s disease (HD) patients who failed prior mobilization with other regimens Biology of Blood and Marrow Transplantation ·Gary Calandra, John M. McCarty, Joseph P. McGuirk, Bart Barlogie, Sue-Anne Crocker, Karin Badel	2007	4
20	Steady State Mobilization of Autologous Blood Stem Cells Using G-CSF and AMD3100 in Patients with Multiple Myeloma (MM). Blood ·Gerhard Ehninger, Stefan Früehauf, Kai Hübel, Uwe Platzbecker, Karin Badel, Gary Calandra	2006	4

About Karin Badel

Karin Badel is a scholar working on Hematology, Virology, Immunology, Genetics and Oncology, having authored 27 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (17 papers), Multiple Myeloma Research and Treatments (12 papers), Acute Myeloid Leukemia Research (10 papers), Immunotherapy and Immune Responses (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Chemokine receptors and signaling (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Hematology (1.0k citations), Virology (141 citations), Immunology (623 citations), Oncology (766 citations) and Genetics (203 citations). Karin Badel has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Gary Calandra, Gary Calandra, Gary Bridger, John F. DiPersio, Jane L. Liesveld, Daniel J. Weisdorf, Neal Flomenberg, Steven M. Devine, David H. Vesole and R. T. MacFarland. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, Clinical Pharmacology & Therapeutics and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact